Month: December 2019

2024.07.17
Summary of the most important events and achievements of the Genomtec S.A.

2024.06.25
Webinar: Trends in the M&A Market Specific to In-Vitro Diagnostics | 27 June, 2024, 3:00 p.m. (CEST)

2024.04.22
Dr. Trevor Hawkins, a distinguished entrepreneur, scientist, and leader with experience in global healthcare companies, has joined the Supervisory Board of Genomtec S.A.

2024.03.26
Genomtec secures PLN 10.6 million to fund scientific research and development of the oncology project - Company will raise capital from founding shareholders and investors

2024.03.26
Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

Archive

2019.12.10

MicroRNA-based tool for non-invasive early-stage cancer diagnosis — GenomtecTumor

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 885874 The ...
Read
2019.12.02

Genomtec takes fast track forward

After approved financing of almost 2.5 million USD from National Center for Research and Development as a non-dilutive grant Genomtec further ...
Read

Archive